Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (271-280 of 345) with videos related to

Pageof 35
Sort By:
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Rheumatology (Oxford, England)|March 25, 2022
Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.
Rheumatology (Oxford, England)|February 9, 2022
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Annals of the Rheumatic Diseases|March 13, 2020
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and SwedenTine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, et al.
Rheumatology (Oxford, England)|January 5, 2021
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyKarin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, et al.
Annals of the Rheumatic Diseases|November 27, 2013
Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twinsAase Haj Hensvold, Patrik K E Magnusson, Vijay Joshua, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
RMD Open|September 9, 2020
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersKaterina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, et al.
Pageof 35

Showing results (271-280 of 345) with videos related to

Sort By:
Pageof 35
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Rheumatology (Oxford, England)|March 25, 2022
Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.
Rheumatology (Oxford, England)|February 9, 2022
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Annals of the Rheumatic Diseases|March 13, 2020
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and SwedenTine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, et al.
Rheumatology (Oxford, England)|January 5, 2021
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyKarin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, et al.
Annals of the Rheumatic Diseases|November 27, 2013
Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twinsAase Haj Hensvold, Patrik K E Magnusson, Vijay Joshua, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
RMD Open|September 9, 2020
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersKaterina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, et al.
Pageof 35